Stocks and Investing
Stocks and Investing
Wed, June 13, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 12, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Charles Duncan Initiated (BHVN) at Buy and Held Target at $42 on, Jun 12th, 2018
Charles Duncan of Cantor Fitzgerald, Initiated "Biohaven Ltd." (BHVN) at Buy and Held Target at $42 on, Jun 12th, 2018.
Charles has made no other calls on BHVN in the last 4 months.
There are 2 other peers that have a rating on BHVN. Out of the 2 peers that are also analyzing BHVN, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Thursday, April 5th, 2018
This is the rating of the analyst that currently disagrees with Charles
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $34 on, Tuesday, March 27th, 2018